Jianda Biopharmaceuticals
Company Details
Status: Private
Employees: 1-10
Location:
Type:
sample
sample
Technology:
sample
sample
sample
About: Founded in 2018, Jianda Biopharmaceuticals (Nanjing) Co., Ltd. is a biopharmaceutical company founded by domestic and foreign vaccine research and development, industrialization and commercialization experts and an elite team in the pharmaceutical industry. Its headquarters is located in the Biopharmaceutical Valley of Nanjing Jiangbei New District.
Driven by independent innovative technologies, Jianda Biopharma focuses on the development and industrialization of new human vaccines and biopharmaceutical products such as tumor treatment. Since its establishment, the company has devoted itself to research and development and established a DC-targeted VLP vaccine technology platform and a circular mRNA vaccine technology platform with independent intellectual property rights. A series of innovative products based on platform technologies are in the POC, pilot production and pre-IND stages.
In 2021, the company completed its angel round of financing, with Shenzhen Songshan Capital and Dongguan Juying Capital investing 33 million yuan, pushing multiple of the company's products from R&D to pre-IND.
The company focuses on the field of life and health, introduces company teams, insists on pioneering and innovation, deploys multiple product pipelines, and strives to bring new vaccines developed to the market to benefit human life and health.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Jianda Biopharmaceuticals | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.